Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
56,213,687
-
Share change
-
+11,225,741
-
Total reported value
-
$101,187,932
-
Put/Call ratio
-
91%
-
Price per share
-
$1.80
-
Number of holders
-
111
-
Value change
-
-$33,267,977
-
Number of buys
-
55
-
Number of sells
-
63
Institutional Holders of CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) as of Q3 2020
As of 30 Sep 2020,
CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,213,687 shares.
The largest 10 holders included
STATE STREET CORP, BlackRock Inc., Knoll Capital Management, LP, VANGUARD GROUP INC, ETF MANAGERS GROUP, LLC, D. E. Shaw & Co., Inc., FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, SG Americas Securities, LLC, and PINNACLE ASSOCIATES LTD.
This page lists
111
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.